Illumina Reports Fiscal Third-Quarter 2026 Financial Results
Illumina announced results for the third quarter of fiscal 2026. The supplied excerpt says healthy clinical demand and robust NovaSeq X placements drove results.
Story updates
08:09:28 PM UTC
SquawkNews
Illumina reported Q3 FY26 results above its guidance, driven by clinical demand and NovaSeq X placements, and raised full-year revenue and earnings guidance. Q3 free cash flow was $378M and cash/investments were $1.34B.Material DetailsContext by AI AnalystThis is a mid-cycle confirmation that deman…
08:23:07 PM UTC
SquawkNews
Beneficio neto de Illumina sube un 47% interanual a 220 millones de dólares en el tercer trimestre d